TABLE 3.
Susceptibility profiles of commonly used antimicrobials for Nocardia species with multidrug resistant isolates
Organism (n) | Determination for: |
n | % | |||
---|---|---|---|---|---|---|
TMP-SXT | AMK | IMI | CTR | |||
N. abscessus complex (110) | S | S | S | S | 33 | 30 |
S | S | S | R/I | 1 | 0.9 | |
S | S | R/I | S | 75 | 68 | |
S | S | R/I | R/I | 1 | 0.9 | |
N. amikacinitolerans (7) | S | S | S | S | 2 | 29 |
S | S | R/I | S | 1 | 14 | |
S | R | S | S | 1 | 14 | |
S | R | S | R/I | 2 | 29 | |
S | R | R/I | R/I | 1 | 14 | |
N. aobensis (2) | S | S | S | S | 1 | 50 |
S | S | R/I | R/I | 1 | 50 | |
N. brasiliensis (148) | S | S | S | S | 1 | 0.7 |
S | S | R/I | S | 72 | 48 | |
S | S | R/I | R/I | 75 | 51 | |
N. cyriacigeorgica (264) | S | S | S | S | 106 | 40 |
S | S | S | R/I | 7 | 3 | |
S | S | R/I | S | 127 | 48 | |
S | S | R/I | R/I | 24 | 9 | |
N. farcinica (204) | S | S | S | S | 6 | 3 |
S | S | S | R/I | 60 | 29 | |
S | S | R/I | R/I | 137 | 67 | |
R | S | R/I | R/I | 1 | 0.5 | |
N. nova complex (320) | S | S | S | S | 151 | 47 |
S | S | S | R/I | 165 | 52 | |
S | S | R/I | R/I | 4 | 1 | |
N. pseudobrasiliensis (13) | S | S | R/I | R/I | 7 | 54 |
S | R | R/I | R/I | 2 | 15 | |
R | S | R/I | R/I | 2 | 15 | |
R | R | R/I | R/I | 2 | 15 | |
N. puris (7) | S | S | S | S | 1 | 14 |
S | S | S | R/I | 2 | 29 | |
S | S | R/I | R/I | 4 | 57 | |
N. transvalensis complex (83) | S | S | S | S | 2 | 2 |
S | S | S | R/I | 1 | 1 | |
S | S | R/I | S | 9 | 11 | |
S | S | R/I | R/I | 8 | 10 | |
S | R | S | S | 2 | 2 | |
S | R | R/I | S | 28 | 34 | |
S | R | R/I | R/I | 17 | 20 | |
R | S | R/I | S | 1 | 1 | |
R | S | R/I | R/I | 2 | 2 | |
R | R | R/I | S | 10 | 12 | |
R | R | R/I | R/I | 3 | 4 |